Description

Much has been learned about the diversity of the roughly 40 trillion bacterial cells that make up the human body, and the nearly 1,000 species of bacteria that can be found in the gut microbiome. But researchers are just now beginning to close the gap on the relationship between live microbe intake and specific health outcomes. Reversing gut dysbiosis has shown positive impact on gastrointestinal (GI), respiratory, immunological and cardiovascular health, weight management and chronic disease avoidance, even mood, psychology and cognitive ability. It’s an exciting time for companies producing strain-specific probiotics and supplements, prebiotic nutrients helping to promote positive bacteria, synbiotic combinations of the two, and new postbiotic solutions that are challenging the decades-old stability and regulatory framework of the sector.

This session will cover:

• An exploration of the volume and nature of evidence to support health benefits
• Perspectives from the registered dietician and health care practitioner sector about how to best reach end-consumers with microbiome solutions
• Market data insights on consumer buying and delivery formats
• Innovators on the technological front lines who aim to biohack the multitude of human microbial communities and influence their impact on health and performance

Separate registration required.

In partnership with:

Underwritten by:

• Education Sessions